LncPTEN1, a long non-coding RNA generated from PTEN, suppresses lung cancer metastasis through the regulation of EMT progress

  • 0Institute of Systems Biomedicine, Department of Pathology, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking-Tsinghua Center of Life Sciences, Peking University Health Science Center, Beijing, 100191, China.

|

|

Summary

This summary is machine-generated.

A novel long non-coding RNA, LncPTEN1, derived from the PTEN gene, suppresses lung cancer metastasis. Low LncPTEN1 expression correlates with poor survival, highlighting its potential as a prognostic biomarker.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Lung cancer is a leading cause of cancer-related mortality worldwide.
  • Metastasis is a key factor influencing patient prognosis in lung cancer.
  • The tumor suppressor PTEN plays a role in lung cancer, but its metastasis-suppressing mechanisms require further elucidation.

Purpose Of The Study

  • To identify and characterize novel molecular mechanisms underlying PTEN's tumor-suppressive function in lung cancer metastasis.
  • To investigate the role of long non-coding RNAs (lncRNAs) derived from the PTEN gene in lung cancer progression.

Main Methods

  • Identification and characterization of a novel lncRNA, LncPTEN1, transcribed from the PTEN gene.
  • Analysis of LncPTEN1 expression in normal and cancerous lung cells.
  • Correlation of LncPTEN1 expression levels with clinical data from lung cancer patient cohorts.
  • Mechanistic studies involving protein-protein interactions, ubiquitination assays, and proteasomal degradation analysis.

Main Results

  • LncPTEN1, a novel lncRNA from the PTEN gene, was identified and characterized.
  • YTHDC1 was found to promote alternative splicing of LncPTEN1, increasing its expression in normal lung cells.
  • Low LncPTEN1 expression was significantly associated with poorer patient survival and increased metastasis.
  • LncPTEN1 was shown to inhibit epithelial-mesenchymal transition (EMT)-driven metastasis by promoting Vimentin degradation.

Conclusions

  • LncPTEN1 is a novel tumor-suppressive lncRNA that inhibits lung cancer metastasis.
  • LncPTEN1 functions by facilitating the interaction between Trim16 and Vimentin, leading to Vimentin's ubiquitination and proteasomal degradation.
  • LncPTEN1 holds potential as a prognostic biomarker for lung cancer patients.

Related Concept Videos

lncRNA - Long Non-coding RNAs 02:39

9.0K

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Metastasis 02:30

5.7K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Non-LTR Retrotransposons 03:18

11.9K

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

MicroRNAs 01:22

21.8K

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Abnormal Proliferation 02:23

4.6K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer-Critical Genes II: Tumor Suppressor Genes 01:05

8.2K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...